A Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy

Prostate cancer patients will be stratified based on seminal vesicle involvement, gleason
score, pre-radiotherapy PSA level, and PSA doubling time. Patients will then be randomized
to either Arm I only with prostate bed radiation therapy, Arm 2 with prostate bed radiation
therapy plus androgen deprivation oral therapy for 4-6 months, or Arm 3 with prostate bed
and pelvic lymph node radiation therapy plus androgen deprivation oral therapy for 4-6
months.